Contact | Print version | PDF version | Send article | RSS feed

Generex Biotechnology Awarded New Drug Delivery Patent

Company Expands Australian Patent Portfolio

29 Oct 2008 - Generex Biotechnology Corporation announced that it has received a new patent in Australia. The Australian Patent Office has granted the Company a patent titled Micellar Pharmaceutical Compositions for Buccal and Pulmonary Application. The patent contains formulation and method claims to a pharmaceutical formulation comprising a macromolecular pharmaceutical agent in mixed micellar form, and metered dose device containing said formulation, for buccal administration.
 
"We are pleased to include this latest patent to our expanding portfolio," said Rose Perri, the Company's Chief Operating Officer. "While we continue to move forward with the regulatory process in major markets, we continue to work on patent submissions for other jurisdictions."
 
Generex currently holds an aggregate of 128 patents worldwide (21 of which are United States Patents) and has an aggregate of 134 patent applications pending in various jurisdictions.